Drugs in Sports: Compromising the Health of Athletes and Undermining the Integ- Rity of Competition

Total Page:16

File Type:pdf, Size:1020Kb

Drugs in Sports: Compromising the Health of Athletes and Undermining the Integ- Rity of Competition DRUGS IN SPORTS: COMPROMISING THE HEALTH OF ATHLETES AND UNDERMINING THE INTEG- RITY OF COMPETITION HEARING BEFORE THE SUBCOMMITTEE ON COMMERCE, TRADE, AND CONSUMER PROTECTION OF THE COMMITTEE ON ENERGY AND COMMERCE HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS SECOND SESSION FEBRUARY 27, 2008 Serial No. 110–93 ( Printed for the use of the Committee on Energy and Commerce energycommerce.house.gov U.S. GOVERNMENT PRINTING OFFICE 49–522 PDF WASHINGTON : 2008 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 VerDate Nov 24 2008 12:30 Jun 01, 2009 Jkt 037690 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 C:\DOCUMENTS AND SETTINGS\CWELLS1\110-93 SCOM1 PsN: JIMC COMMITTEE ON ENERGY AND COMMERCE JOHN D. DINGELL, Michigan,Chairman HENRY A. WAXMAN, California JOE BARTON, Texas EDWARD J. MARKEY, Massachusetts Ranking Member RICK BOUCHER, Virginia RALPH M. HALL, Texas EDOLPHUS TOWNS, New York J. DENNIS HASTERT, Illinois FRANK PALLONE, JR., New Jersey FRED UPTON, Michigan BART GORDON, Tennessee CLIFF STEARNS, Florida BOBBY L. RUSH, Illinois NATHAN DEAL, Georgia ANNA G. ESHOO, California ED WHITFIELD, Kentucky BART STUPAK, Michigan BARBARA CUBIN, Wyoming ELIOT L. ENGEL, New York JOHN SHIMKUS, Illinois ALBERT R. WYNN, Maryland HEATHER WILSON, New Mexico GENE GREEN, Texas JOHN B. SHADEGG, Arizona DIANA DEGETTE, Colorado CHARLES W. ‘‘CHIP’’ PICKERING, Vice Chairman Mississippi LOIS CAPPS, California VITO FOSSELLA, New York MIKE DOYLE, Pennsylvania STEVE BUYER, Indiana JANE HARMAN, California GEORGE RADANOVICH, California TOM ALLEN, Maine JOSEPH R. PITTS, Pennsylvania JAN SCHAKOWSKY, Illinois MARY BONO, California HILDA L. SOLIS, California GREG WALDEN, Oregon CHARLES A. GONZALEZ, Texas LEE TERRY, Nebraska JAY INSLEE, Washington MIKE FERGUSON, New Jersey TAMMY BALDWIN, Wisconsin MIKE ROGERS, Michigan MIKE ROSS, Arkansas SUE WILKINS MYRICK, North Carolina DARLENE HOOLEY, Oregon JOHN SULLIVAN, Oklahoma ANTHONY D. WEINER, New York TIM MURPHY, Pennsylvania JIM MATHESON, Utah MICHAEL C. BURGESS, Texas G.K. BUTTERFIELD, North Carolina MARSHA BLACKBURN, Tennessee CHARLIE MELANCON, Louisiana JOHN BARROW, Georgia BARON P. HILL, Indiana PROFESSIONAL STAFF DENNIS B. FITZGIBBONS,Chief of Staff GREGG A. ROTHSCHILD,Chief Counsel SHARON E. DAVIS,Chief Clerk DAVID L. CAVICKE,Minority Staff Director (II) VerDate Nov 24 2008 12:30 Jun 01, 2009 Jkt 037690 PO 00000 Frm 00002 Fmt 0486 Sfmt 0486 C:\DOCUMENTS AND SETTINGS\CWELLS1\110-93 SCOM1 PsN: JIMC SUBCOMMITTEE ON COMMERCE, TRADE, AND CONSUMER PROTECTION BOBBY L. RUSH, Illinois,Chairman JAN SCHAKOWSKY, Illinois CLIFF STEARNS, Florida, Vice Chairman Ranking Member G.K. BUTTERFIELD, North Carolina J. DENNIS HASTERT, Illinois JOHN BARROW, Georgia ED WHITFIELD, Kentucky BARON P. HILL, Indiana CHARLES W. ‘‘CHIP’’ PICKERING, EDWARD J. MARKEY, Massachusetts Mississippi RICK BOUCHER, Virginia VITO FOSSELLA, New York EDOLPHUS TOWNS, New York GEORGE RADANOVICH, California DIANA DEGETTE, Colorado JOSEPH R. PITTS, Pennsylvania CHARLES A. GONZALEZ, Texas MARY BONO, California MIKE ROSS, Arkansas LEE TERRY, Nebraska DARLENE HOOLEY, Oregon SUE WILKINS MYRICK, North Carolina ANTHONY D. WEINER, New York MICHAEL C. BURGESS, Texas JIM MATHESON, Utah MARSHA BLACKBURN, Tennessee CHARLIE MELANCON, Louisiana JOE BARTON, Texas (ex officio) JOHN D. DINGELL, Michigan (ex officio) (III) VerDate Nov 24 2008 12:30 Jun 01, 2009 Jkt 037690 PO 00000 Frm 00003 Fmt 5904 Sfmt 5904 C:\DOCUMENTS AND SETTINGS\CWELLS1\110-93 SCOM1 PsN: JIMC VerDate Nov 24 2008 12:30 Jun 01, 2009 Jkt 037690 PO 00000 Frm 00004 Fmt 5904 Sfmt 5904 C:\DOCUMENTS AND SETTINGS\CWELLS1\110-93 SCOM1 PsN: JIMC C O N T E N T S Page Hon. Bobby L. Rush, a Representative in Congress from the State of Illinois, opening statement ................................................................................................ 1 Hon. Ed Whitfield, a Representative in Congress from the Commonwealth of Kentucky, opening statement ......................................................................... 3 Hon. Jan Schakowsky, a Representative in Congress from the State of Illi- nois, opening statement ....................................................................................... 4 Hon. Cliff Stearns, a Representative in Congress from the State of Florida, opening statement ................................................................................................ 6 Hon. Edward J. Markey, a Representative in Congress from the State of Massachusetts, opening statement ..................................................................... 7 Hon. Marsha Blackburn, a Representative in Congress from the State of Tennessee, opening statement ............................................................................ 8 Hon. Anthony D. Weiner, a Representative in Congress from the State of New York, opening statement ............................................................................. 10 Hon. Lee Terry, a Representative in Congress from the State of Nebraska, opening statement ................................................................................................ 11 Hon. Michael C. Burgess, a Representative in Congress from the State of Texas, opening statement .................................................................................... 12 Hon. Joseph R. Pitts, a Representative in Congress from the Commonwealth of Pennsylvania, opening statement ................................................................... 13 Hon. John D. Dingell, a Representative in Congress from the State of Michi- gan, prepared statement ...................................................................................... 180 WITNESSES Hon. George J. Mitchell, a United States Senator from the State of Maine, prepared statement .............................................................................................. 14 Allan H. ‘‘Bud’’ Selig, commissioner, The Office of the Commissioner of Base- ball ......................................................................................................................... 18 Prepared statement .......................................................................................... 20 Donald Fehr, executive director, Major League Baseball Players Association ... 21 Prepared statement .......................................................................................... 24 David Stern, commissioner, National Basketball Association ............................. 37 Prepared statement .......................................................................................... 37 G. William Hunter, executive director, National Basketball Players Associa- tion ........................................................................................................................ 40 Prepared statement .......................................................................................... 42 Roger Goodell, commissioner, National Football League ..................................... 44 Prepared statement .......................................................................................... 48 Gene Upshaw, executive director, National Football League Players Associa- tion ........................................................................................................................ 46 Prepared statement .......................................................................................... 48 Gary Bettman, commissioner, National Hockey League ...................................... 90 Prepared statement .......................................................................................... 92 Paul Kelly, executive director, National Hockey League Players Association ... 98 Prepared statement .......................................................................................... 100 Jim Scherr, chief executive officer, U.S. Olympic Committee, Colorado Springs, Colorado ................................................................................................. 145 Prepared statement .......................................................................................... 148 Travis T. Tygart, chief executive officer, U.S. Anti-Doping Agency, Colorado Springs, Colorado ................................................................................................. 149 Prepared statement .......................................................................................... 151 Myles Brand, president, National Collegiate Athletics Association, Indianap- olis, Indiana .......................................................................................................... 154 Prepared statement .......................................................................................... 156 (V) VerDate Nov 24 2008 12:30 Jun 01, 2009 Jkt 037690 PO 00000 Frm 00005 Fmt 5904 Sfmt 5904 C:\DOCUMENTS AND SETTINGS\CWELLS1\110-93 SCOM1 PsN: JIMC VI Page Robert Kanaby, executive director, National Federation of State High School Associations, Indianapolis, Indiana .................................................................... 161 Prepared statement .......................................................................................... 163 Alexander M. Waldrop, chief executive officer, National Thoroughbred Racing Assocation, Lexington, Kentucky ........................................................................ 165 Prepared statement
Recommended publications
  • Sportsletter Interview: Shaun Assael
    SportsLetter Interviews December 2007 Volume 18, No. 6 Shaun Assael With the recent release of the Mitchell Report, the story of steroids in Major League Baseball has dominated sports coverage. The report states, “Everyone involved in baseball over the past two decades — Commissioners, club officials, the Players Association, and the players — shares to some extent in the responsibility for the steroids era. There was a collective failure to recognize the problem as it emerged and deal with it early on.” For all the hand-wringing about Major League Baseball’s mea culpa, the use of anabolic steroids and other performance- enhancing drugs has been sports’ dirty little not-so-secret for decades. In his book, “Steroid Nation: Juiced Home Run Totals, Anti-aging Miracles, and a Hercules in Every High School: The Secret History of America’s True Drug Addiction” (ESPN Books), ESPN staff writer Shaun Assael traces the culture of steroids in sports. The tale is about as long as the sub-title of the book, and Assael chronicles the many twists of this complex story. He writes about the long-forgotten “visionaries” (like Dan Duchaine, author of the “Underground Steroid Handbook”), the athletes who became caught in cycles of steroid abuse (NFL star Lyle Alzado) and the research scientists charged to nab them (UCLA’s Dr. Don Catlin). The result is a panoramic view of steroids in America — a view that echoes the Mitchell Report in placing responsibility for the spread of performance-enhancing drugs on just about everyone including the media 1 ©1996-2008 LA84 Foundation. Reproduction of SportsLetter is encouraged with credit to the LA84 Foundation.
    [Show full text]
  • Effects of Performance Enhancing Drugs on the Health of Athletes and Athletic Competition
    S. HRG. 106–1074 EFFECTS OF PERFORMANCE ENHANCING DRUGS ON THE HEALTH OF ATHLETES AND ATHLETIC COMPETITION HEARING BEFORE THE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION UNITED STATES SENATE ONE HUNDRED SIXTH CONGRESS FIRST SESSION OCTOBER 20, 1999 Printed for the use of the Committee on Commerce, Science, and Transportation ( U.S. GOVERNMENT PRINTING OFFICE 75–594 PDF WASHINGTON : 2002 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2250 Mail: Stop SSOP, Washington, DC 20402–0001 VerDate 11-MAY-2000 10:45 Jun 07, 2002 Jkt 075594 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 75594.TXT SCOM1 PsN: SCOM1 SENATE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION ONE HUNDRED SIXTH CONGRESS FIRST SESSION JOHN MCCAIN, Arizona, Chairman TED STEVENS, Alaska ERNEST F. HOLLINGS, South Carolina CONRAD BURNS, Montana DANIEL K. INOUYE, Hawaii SLADE GORTON, Washington JOHN D. ROCKEFELLER IV, West Virginia TRENT LOTT, Mississippi JOHN F. KERRY, Massachusetts KAY BAILEY HUTCHISON, Texas JOHN B. BREAUX, Louisiana OLYMPIA J. SNOWE, Maine RICHARD H. BRYAN, Nevada JOHN ASHCROFT, Missouri BYRON L. DORGAN, North Dakota BILL FRIST, Tennessee RON WYDEN, Oregon SPENCER ABRAHAM, Michigan MAX CLELAND, Georgia SAM BROWNBACK, Kansas MARK BUSE, Staff Director MARTHA P. ALLBRIGHT, General Counsel IVAN A. SCHLAGER, Democratic Chief Counsel and Staff Director KEVIN D. KAYES, Democratic General Counsel (II) VerDate 11-MAY-2000 10:45 Jun 07, 2002 Jkt 075594 PO 00000 Frm 00002 Fmt 5904 Sfmt 5904 75594.TXT SCOM1 PsN: SCOM1 C O N T E N T S Page Hearing held October 20, 1999 ..............................................................................
    [Show full text]
  • Performance-Enhancing Drugs in Sports: How Chemists Catch Users
    In the Classroom Performance-Enhancing Drugs in Sports: How Chemists Catch Users T. C. Werner* Chemistry Department, Union College, Schenectady, New York 12308, United States *[email protected] Caroline K. Hatton Sports Anti-Doping Science Consultant, P.O. Box 4795, Culver City, California 90231-4795, United States What do the following prominent athletes have in com- Olympic Analytical Laboratory and Anti-Doping Research, Inc. mon: Floyd Landis, Mark McGwire, Marion Jones, Ben Johnson, A description of the course can be found on the Web (3). and Lyle Alzado? All have been suspected of using performance- enhancing drugs (PEDs) in recent decades and have eventually Stimulants confessed. Over this period, major doping investigations have included the BALCO (Bay Area Laboratory Co-Operative) case, Athletes have used stimulants, such as caffeine, strychnine, which involved doping in various sports instigated by a company and cocaine since the 19th century (4). The 2010 WADA list in the San Francisco area, and the Mitchell Report, which prohibits all stimulants in competition and names about describes PED use (particularly steroids) in Major League Base- 60 examples. The most notorious is amphetamine (Figure 1), ball (MLB). Moreover, the Tour de France has been wracked by which stimulates the central nervous system by releasing doping allegations for decades, causing teams to lose sponsors neurotransmitters, such as dopamine, into the synapse between recently and struggle to maintain fan support, even in cycling- neurons. As a result, amphetamine combats fatigue (5).Stimu- crazy Europe. All of the sports headlines generated by these lantabuseputsathletesatriskforheartrhythmanomaliesand incidents have a chemical “back story” that is rich in relevant for injury to themselves and their competitors, among other examples for undergraduate chemistry and biochemistry courses, things.
    [Show full text]
  • Baseball Statistics in the Steroids Era
    BASEBALL STATISTICS IN THE STEROIDS ERA _________________________ By John Dechant _________________________ A THESIS Submitted to the faculty of the Graduate School of the Creighton University in Partial Fulfillment of the Requirements for the degree of Master of the Arts in the Department of Liberal Studies. _________________________ OMAHA, NEBRASKA JUNE 27, 2008 iii Abstract This thesis examines the presence of steroids and performance enhancing substances in Major League Baseball from approximately 1988 to 2008. This period, informally known as the “steroids era,” has been the source of great controversy in recent years as more and more information on the matter has been disclosed to the public. In particular, this discussion focuses on the records and statistics of this era. In addition to the players who achieved these statistics, these numbers should be under great scrutiny as their validity is questioned. CONTENTS PREFACE………………………………………………………………………………iv INTRODUCTION……………………………………………………………………….1 Chapter ONE HISTORICAL PATTERNS OF STEROID USE IN BASEBALL………5 The Nature of Performance Enhancing Substances………………5 Early Signs of Steroid Use in Major League Baseball…………....8 Early Major League Baseball Steroid Policy…………………….12 Contemporary Steroid Use in Major League Baseball and the Evolution of Testing Policy……………………………..14 Congressional Intervention and the Mitchell Report…………….23 TWO ETHICAL CONSIDERATIONS OF STEROIDS IN BASEBALL……32 The Prohibition Debate………………………………………….32 Records and Statistics……………………………………………46 THREE *ASTERISKS AND DISTINGUISHING MARKS……………………..54 Problems of the Steroids Era…......................................................54 Precedents………………………………………………………..60 Asterisk…………………………………………………………..62 Era Divide………………………………………………………..65 Status Quo………………………………………………………..66 Assessment……………………………………………………….67 CONCLUSION…………………………………………………………………………..70 BIBLIOGRAPHY………………………………………………………………………..71 iv Preface My opinion of steroids and performance enhancing substances in baseball changed on February 13, 2008.
    [Show full text]
  • The Timeless Beneficial Bloom Herb Profile Hawthorn Crataegus Monogyna, C
    HerbalGram 96 • November 2012 - January 2013 HerbalGram 96 • November 2012 - January 2013 Largest Echinacea Trial • Bilberry Adulteration • Sports and Supplements Federal Cannabis Crackdown • Bacopa and Memory • Butterbur and Migraine The Journal of the American Botanical Council Number 96 | November 2012 - January 2013 Turkish RoseTurkish • Trial Largest • Echinacea Bilberry Adulteration • Sports and Supplements • Cannabis Crackdown Federal • Bacopa and Memory • Butterbur and Migraine US/CAN $6.95 www.herbalgram.org Rose www.herbalgram.org The Timeless Beneficial Bloom Herb Profile Hawthorn Crataegus monogyna, C. laevigata Family: Rosaceae INTRODUCTION HISTORY AND CULTURAL SIGNIFICANCE Hawthorn is a large shrub or small tree (15-30 feet on The generic name, Crataegus, comes from the Greek kratos, average) in the genus Crataegus, native to temperate North meaning hard or strong, referring to the plant’s wood.13,14 America, Europe, and East Asia.1 The plants are indetermi- The common name refers to the plant’s thorns and fruit, nately thorny, with variable shape, and have perfect, radially known as haws, and may also refer to its use to form hedges, symmetrical, 5-petaled white to pink flowers (red in some which were called haws in earlier times.13 Other common M I S S I O N D R I V E N : cultivars) in corymbs (flat-topped clusters).2,3 The red fruit names for C. laevigata include English hawthorn, white are drupes (one-seeded and fleshy) but are commonly called thorn, May tree (referring to when it blooms), and two- berries in the trade. The genus Crataegus comprises approxi- style hawthorn; and English hawthorn, one-seed hawthorn, mately 250-280 species, the most commonly used in West- and one-style hawthorn for C.
    [Show full text]
  • Note Balancing the Justices in Anti
    Note Balancing the Justices in Anti-Doping Law: The Need to Ensure Fair Athletic Competition Through Effective Anti-Doping Programs vs. the Protection of Rights of Accused Athletes Ryan Connolly∗ Introduction................................................................................................... 42 I. Structure of the Current International System .......................................... 43 A. Court of Arbitration for Sport........................................................... 43 B. U.S. Anti-Doping Agency ................................................................ 45 II. Unique Issues Contributing to Anti-Doping’s Jurisprudential Community ............................................................................................ 46 A. Scientific Limitations........................................................................ 46 B. Pharmaceutical Innovations.............................................................. 49 C. Dietary Supplements......................................................................... 50 D. Designer Steroids.............................................................................. 52 E. Effect on Anti-Doping Law.............................................................. 54 III. Anti-Doping Jurisprudence ..................................................................... 54 A. Procedural Issues.............................................................................. 54 ∗ The author of this essay has been the Business Manager and Consultant for the UCLA Olympic Analytical
    [Show full text]
  • Leveling the Playing Field
    By Nancy Sokoler Steiner '85 Available legally by prescription for medical conditions that involve low levels of testosterone production, anabolic steroids have found favor '"WfNG FIELD among athletes who want a boost to build mus cle mass and strength. However, they can cause A UCLA laboratory takes on the serious physical and psychological problems, latest designer steroids and are banned by the IOC, NCAA and NFL. Nevertheless, some athletes willingly risk sanc tions and their health for the chance to break a world record or win a medal. Don Catlin is in a race. Part marathon, part sprint, "The Olympic Analytical Laboratory is the Shortly after the 2002 Winter Olympics in the contest pits the 65-year-old Catlin against only lab that we use for NCAA work — it's the Salt Lake City, Catlin's lab encountered an world-class Olympians, champion cyclists and best sports drug-testing laboratory in the unusual urine sample that contained a previ professional football players. The endeavor United States," says Frank Uryasz, founder and ously unknown steroid. They traced it to a pow requires endurance, persistence and discipline. president of the National Center for Drug Free erful substance that had been under clinical trial Catlin isn't out to break records or earn Sport, Inc., which administers the NCAA's drug- by a drug company decades earlier. The compa medals. Rather, the Department of Molecular & testing program. "When it comes to deterring ny had halted development due to the drug's Medical Pharmacology professor and his team drug use in sports in the United States, the toxic side effects.
    [Show full text]
  • Illegal Manipulation of Your Body
    ES.010 Chemistry of Sports Illegal manipulation of your body Schedule of events for today: 1. Update on workout on Thursday – in the pool 4 pm. 2. Drugs in sports 3. Introduction to Wind tunnel testing – preview of next week’s class with Kim Blair. Drugs in Sports • Blood Doping, Artificial • THG Oxygen Carriers and • Human Chorionic Erythropoietin (EPO) Gonadotrophin (HCG) • Human Growth Hormone • Adrenocorticotropic Hormone • Anabolic Steroids (ACTH) • Insulin-like Growth Factor • Beta-2-Agonists (IGF-1) • Hormone Antagonists and • Cocaine Modulators • Caffeine • Diuretics • Narcotics • Gene Doping • Cannabinoids • Amphetamines Why do Athletes Take Drugs? There are a large number of reasons why an athlete may decide to take drugs. A selection are listed here: • Pressure to succeed, either from themselves or coaches/family and sponsors (major reason) • Belief that their competitors are taking drugs • Pressure from governments/national authorities (as occurred in the eastern bloc countries in the 60's and 70's) • Financial rewards for outstanding performance • Lack of access to, or funding for training facilities and additional support (nutrition, psychological support) • Community and media attitudes and expectations of success Reference:http://www.teachpe.com/drugs/drugs.php. Drugs in Sports • Blood Doping and Erythropoietin • THG (EPO) • Human Chorionic Gonadotrophin • Human Growth Hormone (HCG) • Anabolic Steroids • Adrenocorticotropic Hormone • Insulin-like Growth Factor (IGF- (ACTH) 1) • Beta-2-Agonists • Cocaine • Hormone Antagonists
    [Show full text]
  • Steroids in Baseball and the Case Against Roger Clemens Daniel Healey
    Marquette Sports Law Review Volume 19 Article 11 Issue 1 Fall Fall of the Rocket: Steroids in Baseball and the Case Against Roger Clemens Daniel Healey Follow this and additional works at: http://scholarship.law.marquette.edu/sportslaw Part of the Entertainment and Sports Law Commons Repository Citation Daniel Healey, Fall of the Rocket: Steroids in Baseball and the Case Against Roger Clemens , 19 Marq. Sports L. Rev. 289 (2008) Available at: http://scholarship.law.marquette.edu/sportslaw/vol19/iss1/11 This Symposium is brought to you for free and open access by the Journals at Marquette Law Scholarly Commons. For more information, please contact [email protected]. FALL OF THE ROCKET: STEROIDS IN BASEBALL AND THE CASE AGAINST ROGER CLEMENS DANIEL HEALEY* INTRODUCTION - THE ROCKET ON THE HILL Athletes who are chemically propelled to victory do not merely overvalue winning, they misunderstand why winning is properly valued .... Drugs that make sport exotic, by radical intrusions into the body, drain sport of its exemplary power by making it a display of chemistry rather than character. In fact, it becomes a display of some chemists' virtuosity and some athletes' bad character. - George F. Will1 On February 13, 2008, Roger Clemens (Clemens) traveled to Capitol Hill to clear his name. A seven-time Cy Young Award-winning pitcher for the Boston Red Sox, Toronto Blue Jays, New York Yankees, and Houston Astros, "the Rocket" had come to the end of his career, but only the beginning of his legal and media troubles. In December 2007, Clemens's trainer, Brian McNamee (McNamee), had implicated his former employer as a steroids user in the "Mitchell Report," the definitive account of the proliferation of performance-enhancing drugs (PEDs) in Major League Baseball (MLB).2 After facing two months of intense media scrutiny, Clemens traveled to the Hill to testify before the House Committee on Oversight and Government Reform (the "Committee") that he had never used PEDs.
    [Show full text]
  • Attaining Olympus: a Critical Analysis of Performance-Enhancing Drug Law and Policy for the 21St Century
    Franco Book Proof (Do Not Delete) 4/16/19 11:35 PM ATTAINING OLYMPUS: A CRITICAL ANALYSIS OF PERFORMANCE-ENHANCING DRUG LAW AND POLICY FOR THE 21ST CENTURY ALEXANDRA M. FRANCO1 ABSTRACT While high-profile doping scandals in sports always garner attention, the public discussion about the use of performance-enhancing substances ignores the growing social movement towards enhancement outside of sports. This Article discusses the flaws in the ethical origins and justifications for modern anti-doping law and policy. It analyzes the issues in the current regulatory scheme through its application to different sports, such as cycling and bodybuilding. The Article then juxtaposes those issues to general anti-drug law applicable to non-athletes seeking enhancement, such as students and professionals. The Article posits that the current regulatory scheme is harmful not only to athletes but also to people in general—specifically to their psychological well-being—because it derives from a double social morality that simultaneously shuns and encourages the use of performance-enhancing drugs. I. INTRODUCTION “Everybody is going to do what they do.” — Phil Heath, Mr. Olympia champion.2 The relationship between performance-enhancing drugs and American society has been problematic for the past several decades. High- profile doping scandals regularly garner media attention—for example, 1. © Alexandra M. Franco, J.D. The Author is an Affiliated Scholar at the Institute for Science, Law and Technology at IIT Chicago-Kent College of Law. She previously worked as a Judicial Law Clerk for the Honorable Franklin U. Valderrama in the Circuit Court of Cook County, Illinois (the views expressed in this Article are solely those of the Author, and do not represent those of Equal Justice Works or Cook County).
    [Show full text]
  • The Tim Ferriss Show Transcripts Episode 143: Patrick Arnold Show Notes and Links at Tim.Blog/Podcast
    The Tim Ferriss Show Transcripts Episode 143: Patrick Arnold Show notes and links at tim.blog/podcast Tim Ferriss: Greetings, my little Mogwai. This is Tim Ferriss, and I'm going to redo a legal disclaimer for this episode. I don't do many of these, but at the behest of my ever-so-competent legal counsel, allow me to read the following. I am not recommending, endorsing or supporting any of the substances or compounds discussed or described in this interview, particularly, when this applies to illegal, illicit or dangerous compounds or substances. I am interviewing Patrick, furthermore, as a journalist seeking additional information regarding matters of public interest and concern. You should also notice that we have removed a number of names of different folks to protect the innocent, guilty or otherwise. With all of that said, since I've covered my little white ass, please enjoy. [Intro] Hello you freaks out there, and aren't we all freaks at the end of the day? This is Tim Ferriss, and welcome to another episode of The Tim Ferriss Show. If you liked my episode with Dom D’Agostino, the incredible scientist who fasted six, seven days, whatever it was, dead-lifted 500 pounds for ten reps, and continues to do amazing work for the Department of Defense with exogenous ketones, etc., etc., you might love this one. So here we go. Patrick Arnold is widely considered the father of prohormones. He's also an organic chemist known for introducing androstenedione – remember Mark McGuire – 1 androstenediol, marketed as 1AD, and methylhexanamine, if I'm getting that correct, into the dietary supplement market.
    [Show full text]
  • Structure of the Olympic Movement
    STRUCTURE OF THE OLYMPIC MOVEMENT In addition to the International Olympic Committee, the Olympic Movement includes the International Federations (IFs), the National Olympic Committees (NOCs), the Organising Committees for the Olympic Games (OCOGs), the national associations, clubs, the athletes, judges and referees, coaches and the other sports technicians. It also includes other organisations and institutions recognised by the IOC. Final version: 31 January 2002 part 3/4 © copyright IOC 2002, all rights reserved THE INTERNATIONAL OLYMPIC COMMITTEE The International Olympic Committee is the supreme authority of the Olympic Movement. Its role is to promote top-level sport as well as sport for all in accordance with the Olympic Charter. It ensures the regular celebration of the Olympic Games and strongly encourages, by appropriate means, the promotion of women in sport, that of sports ethics and the protection of athletes. In accordance with the recent reforms, the IOC is composed of a maximum of 115 co-opted members who meet in Session at least once a year. The Session elects a President for a term of eight years, renewable once for four years and Executive Board members for terms of four years. By retaining all rights relating to the organisation, marketing, broadcasting and reproduction of the Olympic Games, the IOC ensures the continuity of a unique and universal event. Final version: 31 January 2002 part 3/4 © copyright IOC 2002, all rights reserved THE IOC PRESIDENT The Chevalier Dr Jacques Rogge (Belgium) is the eigthth IOC President. Co-opted into the IOC in 1991 he was elected President on 16th July 2001 by the 112th IOC Session for an eight-year term.
    [Show full text]